The Cannabis Industry Council (CIC) is delighted to announce the shortlisted nominees for the Cannabis Industry Awards 2026, celebrating the individuals whose dedication, expertise and achievements are helping to shape the future of the UK’s cannabis industry. From advancing patient care and scientific research to championing sustainability, advocacy and exceptional

With nominations now closed for the Cannabis Industry Awards 2026, we introduce this year’s judging panel and find out what they will be looking for as they assess the individuals driving progress across the UK cannabis sector. Thank you to everyone who submitted a nomination for this year’s Cannabis Industry

The Cannabis Industry Council (CIC) has announced Beyond Awareness: Patient Choice, Safety & Improved Quality of Life, a live educational broadcast bringing together patients, patient organisations, healthcare professionals, researchers, policymakers and industry leaders to explore the realities of navigating chronic conditions and treatment in the UK. Register now! Taking place

The UK Food Standards Agency (FSA) has issued a letter to stakeholders to clarify the potential impact of the proposed UK-EU Sanitary and Phytosanitary (SPS) Agreement on novel foods, including CBD products. Following enquiries from retailers about what a future SPS agreement could mean for the CBD market, the FSA

The CIC is closely monitoring the anticipated publication of the Advisory Council on the Misuse of Drugs (ACMD) report on medical cannabis, which has been expected to publish this summer and has yet to be released. The CIC made a submission to the call for evidence back in autumn 2025. The report is

The CIC welcomes the appointment of Andy Burnham as Prime Minister and Yvette Cooper as Secretary of State for Health & Social Care. We are optimistic that the new government presents an opportunity for constructive, evidence-led engagement on the future of medical cannabis in the UK. The UK’s medical cannabis

New FOI data has revealed that pharmacist independent prescribers are responsible for the majority of cannabis-based medicinal product (CBPM) prescriptions issued in the UK. The analysis found that pharmacist independent prescribers accounted for 955,471 prescription items, representing 61.9% of the 1.54 million CBPM items prescribed between January 2019 and May

The latest Care Quality Commission (CQC) annual update on controlled drugs offers another encouraging snapshot of the continued development of the UK’s medical cannabis sector. Some of key takeaways include: A 2.3x increase in cannabis-based products for medicinal use (CBPMs) prescribed in the year to 31 March 2025, demonstrating continued

Nominations are now open for the Cannabis Industry Awards 2026, recognising individuals who have made outstanding contributions to the UK’s cannabis sector. The event is kindly presented by Aurora Medicine and MediStack.  Hosted by the Cannabis Industry Council, the Cannabis Industry Awards celebrate excellence, leadership and innovation across the UK’s

The CIC is proud to represent more than 100 member organisations spanning the UK’s cannabis ecosystem, including manufacturers, distributors, clinics, pharmacies, patient organisations, research bodies, professional services, and CBD and industrial hemp businesses. Together, our members account for a significant proportion of prescribing activity, product supply and regulatory engagement across

As the leading trade body voice of the UK’s cannabis industry, the Cannabis Industry Council (CIC) exists to professionalise the sector, influence policy, and create a credible, collaborative platform for businesses shaping the future of cannabis in the UK and globally. Our sponsorship and advertising partners play a vital role

LONDON, UNITED KINGDOM – Tuesday, 2nd June, 2026 – The Cannabis Industry Council “(CIC)”, the leading membership organisation representing the UK’s regulated cannabis sector, announced today the appointment of David Skinner and Dr Chris Hayes as Non-Executive Directors to its Board, voted in by CIC members in e-ballot.  The appointment

Activities under Pillar 3, the CIC’s Education, Awareness & Standards pillar, are progressing this year, with a growing focus on improving patient education, awareness, and the development of meaningful industry standards across the UK medical cannabis industry. Following the release of the CIC’s “Travelling with Medical Cannabis” guide earlier this

In 2026, the Cannabis Industry Council significantly expanded its events and networking programme through our Networking & Events Pillar (Pillar 2), reinforcing our role as the leading convening body for the UK cannabis sector. Through a carefully curated series of newly established CIC Socials, Masterclasses and flagship gatherings, the CIC

Activities under Pillar 1, the CIC’s Policy & Regulatory pillar, have really picked up speed this year. In 2026, we have launched two Taskforces: one dedicated to British Cultivators (including those in the Channel Islands) and the other for MHRA MS/WDA licence holders, which also covers API licence holders. The

Following valuable feedback gathered through the June 2025 CIC Members Survey, the Cannabis Industry Council has undertaken a significant restructuring to ensure the organisation is better positioned to deliver meaningful outcomes for members and the wider UK cannabis sector. Moving away from the previous working group model, the CIC has

The Cannabis Industry Council “(CIC)”, the leading membership organisation representing the UK’s regulated cannabis sector, announced today the publishing of a new patient-focused guide, Travelling with Medical Cannabis, offering practical advice for UK patients navigating the complex and often inconsistent rules around travelling with prescribed medical cannabis.  Whilst medical cannabis

The CIC has responded to DEFRA’s “Call for Information” on a proposed UK–EU Sanitary and Phytosanitary (SPS) Agreement. We are concerned that the SPS Agreement risks undermining the UK’s domestic cultivation sector at a critical stage of its development, especially if no exemptions can be negotiated with the EU. The

In episode 10 of the CIC Podcast, CIC Co-Chairs Tom Gray (of Lumino) and Frances Crewdson (of CannDo Consulting) chat with Luke Strong about their plans and priorities for the CIC, which were guided by feedback from CIC members. This is the final episode of the first series of the

Canindcou Limited (trading as Cannabis Industry Council) is interested in appointing a new Board Director. Full details and how to apply can be found below. Role Overview: The Board Director will play a crucial role in the strategic direction, oversight, and governance of Canindcou Ltd (trading as Cannabis Industry Council).

CIC will shortly be launching our initial taskforces, focused on improving the regulatory and commercial environment for businesses in the supply chain. These will all have a clear remit to deliver outcomes within a defined timescale. Each will consist of businesses with the following, respectively: UK cultivation licence MS /

We are delighted to welcome our new Pillar Leads, who bring extensive expertise and fresh energy to the Cannabis Industry Council. Greer Deal (Global Regulatory Services) – Policy and Regulatory PillarSam Cannon (Beyond Green) – Networking and Collaboration PillarAdam Windish (British Cannabis) – Standards and Awareness Pillar Each Pillar Lead

On 6 November 2025, the Cannabis Industry Council hosted the 2025 Cannabis Industry Awards, bringing together clinicians, innovators, advocates and industry leaders to recognise individuals making a meaningful impact across the UK medical cannabis sector. The evening celebrated excellence, leadership and collaboration across our community. Congratulations to this year’s winners:

The Cannabis Industry Council (CIC) has published new guidance aimed at supporting members and industry professionals with setting up businesses in the UK, managing contracts, and addressing payment practices. The guidance responds to multiple requests from CIC members for practical and legal support around business formation, contractual obligations, and payment